Company / R&D per Share
Entrada Therapeutics, Inc. R&D per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$3.33
FY2025
5-year range
$2.12 / $3.33
FY2023-FY2025
Trend
+11.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2.12 to $3.33 over the past 2 years.
Based on SEC 10-K filings.
3.33 in FY2025.
Improved from $2.12 to $3.33 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 11.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.03 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.33 | +11.6% |
| FY2024 | $2.99 | +40.8% |
| FY2023 | $2.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026